Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern EuropeAccess, Myeloma25 June 2023
Sign up for the MPE webinar on EHA myeloma and AL amyloidosis highlights AL amyloidosis, Conferences, MPE, Myeloma14 June 2023
EHA 2023 highlights in myeloma and AL amyloidosisAL amyloidosis, Conferences, Myeloma, Videos14 June 2023
MPE interviews experts about different aspects of the CARAMBA clinical trialMyeloma, Videos10 April 2023
Listen the voice of myeloma patients in documentary “My myeloma: ready for the steps ahead”Myeloma22 March 2023
ASH 2022 | Myeloma and AL amyloidosis updatesAL amyloidosis, Conferences, Myeloma, Videos12 December 2022
The European Medicines Agency (EMA) approves Melflufen (Pepaxti®) for the treatment of refractory myelomaAccess, Myeloma30 August 2022
